Parallax Volatility Advisers’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Parallax Volatility Advisers’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,300	Closed	-$48K	–	3668
2021 Q2	$48K	Buy	+7,300	New	+$50.3K	﹤0.01%	2656
2020 Q1	–	Sell	-36	Closed	–	–	2910
2019 Q4	$0	Buy	+36	New	+$265	﹤0.01%	2780
2019 Q1	–	Sell	-1,033	Closed	-$10.7K	–	4489
2018 Q4	$17K	Buy	+1,033	New	+$22.7K	﹤0.01%	2429

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Parallax Volatility Advisers's AVEO Position: Q3 2021 in Review

Parallax Volatility Advisers sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2021, closing a stake of 7,300 shares — an estimated $48K sold.

Parallax Volatility Advisers first reported a position in AVEO in Q4 2018 and held it in 3 quarters. The position peaked at $48K in Q2 2021. 52 funds tracked by Wall St. Rank hold AVEO as of Q3 2021.

Parallax Volatility Advisers reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Parallax Volatility Advisers sold 7,300 AVEO Pharmaceuticals, Inc. shares in Q3 2021, an estimated $48K.
Parallax Volatility Advisers first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2018 and held it in 3 quarters.
Parallax Volatility Advisers's AVEO Pharmaceuticals, Inc. position peaked at $48K in Q2 2021.
52 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2021.

Based on Parallax Volatility Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.